Sources

8 Total Sources

Daraxonrasib Nearly Doubles Pancreatic Cancer Survival to 13.2 Months in Phase 3 Trial

USA TODAY1d ago
Daraxonrasib Pancreatic Cancer Drug Nearly Doubles Survival in Phase 3 Trial
Reuters1d ago
Revolution's pancreatic cancer drug doubles survival, boosts quality of life | Reuters
Medical Daily9h ago
A New Drug Just Nearly Doubled Survival for Pancreatic Cancer Patients — Dallas's UT Southwestern Is at the Forefront of What Researchers Are Calling a Historic Breakthrough
AOL1d ago
Molecule to Medicine: How Daraxonrasib is Rewriting Pancreatic Cancer Drug Development
Oncology News Central1d ago
Daraxonrasib Doubles Survival in Pancreatic Cancer at ASCO 2026: A Game-Changer
News Arena India10h ago
How daraxonrasib tamed 'undruggable' pancreatic cancer
Pharmacy Practice News1d ago
Pancreatic Cancer Survival Gains with Daraxonrasib
mims.com1d ago
Daraxonrasib makes history in one of the deadli... | MIMS PH